Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Mammoth Biosciences

Explore full profile

The CRISPR-based platform for disease detection

Brisbane, United StatesFounded 2017Biotech & Life Sciences
Valuation $1–2.5B Last recorded · 2026
Headcount 100–500 Current team size
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Mammoth Biosciences and the history behind them.

At a glance

Founded
2017
Headquarters
Brisbane, United States
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tier

Latest news

Press, funding announcements and product moves mentioning Mammoth Biosciences.

See all news

Investors

19 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Series A4 investors entered at this stage

Series B and later13 investors entered at this stage

  • Plum Alley
  • Foresite Capital
  • Pacific 8 Ventures
  • Senator Investment Group
  • Brook Byers
  • Redmile Group
  • Sixth Street Growth
  • Regeneron Pharmaceuticals
  • University of California
  • Berkeley
  • Greenspring Associates
  • aMoon Fund
  • Decheng Capital

Ownership

Share of equity by holder

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

27% Founders

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Talent

Book a demo to see the people
Employees mapped 160 incl. 4 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 7 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 5 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

5 startups

Former Mammoth Biosciences employees who went on to found companies, sorted by Dealroom signal score.

PreventiveEst. 2025
Lucas HarringtonUnited States
Signal score91
Ancilia BioEst. 2019
David Páez-EspinoUnited States
Signal score84
MirvieEst. 2019
Maneesh JainUnited States
Signal score61
MediKarmaEst. 2021
VKVish KulkarniUnited States
Signal score55
Xella HealthEst. 2023
Adriana DantasUnited States
Signal score54
Explore the full alumni networkBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States98.2%
🇸🇬 Singapore0.8%
🇦🇺 Australia0.8%
🇬🇧 United Kingdom0.8%
4 countries shown
Web traffic by country
14K monthly visits
across markets
🇺🇸 United States70%
🇮🇳 India15.7%
🇪🇸 Spain5%
🇬🇧 United Kingdom3.6%
🇧🇩 Bangladesh2.1%
Top 5 markets shown

Patents

Estimated portfolio value
$23M

46 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Mammoth Biosciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Mammoth Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles